Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa

Journal of Hospital Infection

Volumn 53, Issue 1, 2003, Pages 18-24

  Blot, Stijn ^a   Vandewoude, K ^a   Hoste, E ^a   Colardyn, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

APACHE II; Attributable mortality; Bacteraemia; Intensive care; Outcome; Pseudomonas spp.

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; TOBRAMYCIN;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRITICAL ILLNESS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HEMODYNAMICS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; NONHUMAN; PATIENT CODING; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; SURVIVAL;

ADULT; AGED; APACHE; BACTEREMIA; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; OBSERVATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0347273599     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2002.1329     Document Type: Article

References (28)

1. Siegman-Igra, Y, Ravona, R, Primerman, H, & Giladi, M (1998). Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis, 2 211-215.
2. Gallagher, P, & Watanakunakorn, C (1989). Pseudomonas bacteremia in a community teaching hospital, 1980-1984. Rev Infect Dis, 11 846-852.
3. Flick, M, & Cluff, L (1976). Pseudomonas bacteremia - review of 108 cases. Am J Med, 60 501-508.
4. Hilf, M, Yu, V, Sharp, J, Zuravleff, J, Korvick, R, & Muder, R (1989). Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med, 87 540-546.
5. Chatzinikolaou, I, Abi-Said, D, Bodey, G, Rolston, K, Tarrand, J, & Samonis, G (2000). Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer. Retrospective analysis of 245 episodes. Arch Intern Med, 160 501-509.
6. McKendrick, M, & Geddes, A (1981). Pseudomonas septicaemia in a general hospital - seven years experience. Q J Med, 199 331-344.
7. Bodey, G, Jadeja, L, & Elting, L (1985). Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med, 145 1621-1629.
8. Bisbe, J, Gatell, J, & Puig, J et al. (1988). Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev Infect Dis, 10 629-635.
9. Vidal, F, Mensa, J, & Almela, M et al. (1996). Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Arch Intern Med, 156 2121-2126.
10. Korvick, J, Marsh, J, Starzl, T, & Yu, V (1991). Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery, 109 62-68.
11. Anderson, R, Schafer, L, Olin, D, & Eickhoff, T (1978). Septicemia in renal transplant recipients. Arch Surg, 106 692-694.
12. Blot, S, Vandewoude, K, De Bacquer, D, & Colardyn, F (2002). Nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis, 34 1600-1606.
13. Wenzel, RP (1988). The mortality of hospital-acquired bloodstream infections: need for a new vital statistic?. Int J Epidemiol, 17 225-227.
14. Knaus, WA, Draper, EA, Wagner, DP, & Zimmerman, JE (1985). APACHE II: A severity of disease classification system. Crit Care Med, 13 818-829.
15. Rello, J, Ochagavia, A, & Sabanes, E et al.(2000). Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med, 162 1027-1030.
16. Blot, S, Vandewoude, K, & Colardyn, F (2002). Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients. Eur J Clin Microbiol Infect Dis, 21 471-473.
17. Girou, E, Stephan, F, Novara, A, Safar, M, & Fagon, J- Y (1998). Risk factors and outcome of nosocomial infections: results of a matched matched cohort study of ICU patients. Am J Respir Crit Care Med, 157 1151-1158.
18. Rello, J, Jupert, P, Valles, J, Artigas, A, Rue, M, & Niederman, M (1996). Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis, 23 973-978.
19. Blot, S, Vandewoude, K, Hoste, E, & Colardyn, F (2002). Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med, 162 2229-2235.
20. Blot, S, Vandewoude, K, Hoste, E, & Colardyn, F (2002). Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med, 113 480-485.
21. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Villanova, PA: National Committee for Clinical Laboratory Standards;, 1993 14. NCCLS document M2A5
22. Pittet, D, Tarara, D, & Wenzel, R (1994). Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. J Am Med Assoc, 271 1598-1601.
23. Davis, S, Iannetta, A, & Wedgwood, R (1971). Antibiotics for Pseudomonas aeruginosa sepsis: inadequate proof of efficacy. J Infect Dis, 124 104-106.
24. Baltch, A, & Grifin, P (1977). Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients. Am J Med Sci, 274 119-126.
25. Andriole, V (1979). Pseudomonas bacteremia: can antibiotic therapy improve survival?. J Lab Clin Med, 94 196-200.
26. McCabe, W, & Jackson, G (1962). Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med, 110 847-855.
27. Freid, M, & Vosti, K (1968). The importance of underlying disease in patients with Gram-negative bacteremia. Arch Intern Med, 121 418-423.
28. Bertrand, X, Thouverez, M, & Talon, D et al. (2001). Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med, 27 1263-1268.